Page 108 - 《中国药房》2024年12期
P. 108
参考文献 174-178.
[ 1 ] FARHADI J,NOURI M,SAKHINIA E,et al. Epigenetics CHEN L,WU B H,YAN K. Disproportional method ap-
and Behçet’s disease:DNA methylation specially high‐ plied in ADR signal mining of bevacizumab[J]. Cent
lighted[J]. Iran J Allergy Asthma Immunol,2019,18(5): South Pharm,2018,16(2):174-178.
462-472. [ 9 ] ZHOU Y,CHEN M Y,LIU L B,et al. Difference in gas‐
[ 2 ] 卓楠,周真宝.糖皮质激素治疗葡萄膜炎的疗效分析[J]. trointestinal risk associated with use of GLP-1 receptor
慢性病学杂志,2021,22(3):395-396. agonists:a real-world pharmacovigilance study[J]. Diabe‐
ZHUO N,ZHOU Z B. Analysis of the curative efficacy of tes Metab Syndr Obes,2022,15:155-163.
[10] 张丹丹,张宁,孙河,等 . 基于六经八纲辨证体系分析
glucocorticoid in the treatment of uveitis[J]. Chronic Pa-
272例葡萄膜炎患者相关因素及证候特征[J]. 中国中医
thematol J,2021,22(3):395-396.
眼科杂志,2023,33(8):721-726.
[ 3 ] 王蒙蒙,任戎,李丽,等 . 糖皮质激素在重型及危重型
ZHANG D D,ZHANG N,SUN H,et al. Analysis of
COVID-19 患者中的应用进展[J]. 中南药学,2022,20
related factors and syndrome characteristics in 272
(7):1605-1609.
patients with uveitis based on six-channel and eight-
WANG M M,REN R,LI L,et al. Application of glucocor‐
principle pattern identification[J]. China J Chin Ophthal‐
ticoids in severe and critical COVID-19 patients[J]. Cent
mol,2023,33(8):721-726.
South Pharm,2022,20(7):1605-1609.
[11] 张琛,高炳爱,陈玉欣,等. 结节性红斑的病因及发病机
[ 4 ] U.S. Food and Drug Administration.Drug approval package:
制[J]. 中国麻风皮肤病杂志,2015,31(7):408-410.
Yutiq[EB/OL].(2019-02-07)[2023-11-13]. https://www.
ZHANG C,GAO B A,CHEN Y X,et al. Causes and
accessdata. fda. gov/drugsatfda_docs/nda/2018/210331Orig-
pathogenesis of erythema nodosum[J]. China J Lepr Skin
1s000Lbl.pdf.
Dis,2015,31(7):408-410.
[ 5 ] STEEPLES L R,POCKAR S,JONES N P,et al. Evalua-
[12] JAFFE G J,MARTIN D,CALLANAN D,et al. Fluocino‐
ting the safety,efficacy and patient acceptability of intra‐
lone acetonide implant(Retisert)for noninfectious poste‐
vitreal fluocinolone acetonide(0.2 mcg/day) implant in
rior uveitis:thirty-four-week results of a multicenter ran‐
the treatment of non-infectious uveitis affecting the poste‐
domized clinical study[J]. Ophthalmology,2006,113(6):
rior segment[J]. Clin Ophthalmol,2021,15:1433-1442.
1020-1027.
[ 6 ] LY T,PAMER C,DANG O,et al. Evaluation of natural
[13] BISWAS J,TYAGI M,AGARWAL M,et al. The 0.2 μg/
language processing(NLP)systems to annotate drug
day fluocinolone acetonide intravitreal implant in chronic
product labeling with MedDRA terminology[J]. J Biomed
noninfectious posterior uveitis:a 3-year randomized trial
Inform,2018,83:73-86. in India[J]. Ophthalmol Sci,2023,4(1):100403.
[ 7 ] 夏兰芳,李燕,李克莉,等. 药品不良反应比例失衡分析
[14] 夏旭东,柳鹏程,周明,等. 基于H 省药品不良反应真实
方法信号检测中扬名偏倚及其影响[J]. 中国疫苗和免 世界数据对信号检测方法的比较研究[J]. 中国食品药品
疫,2022,28(6):730-735. 监管,2023(10):42-55.
XIA L F,LI Y,LI K L,et al. Notoriety bias and its impact XIA X D,LIU P C,ZHOU M,et al. Comparative study on
on signal detection of adverse drug reactions using dispro‐ signal detection methods based on real world data of ad‐
portionality analysis:a literature review[J]. Chin J Vaccines verse drug reactions in H province[J]. China Food Drug
Immun,2022,28(6):730-735. Adm Mag,2023(10):42-55.
[ 8 ] 陈力,吴邦华,闫康. 比例失衡法在贝伐珠单抗药品不良 (收稿日期:2023-12-22 修回日期:2024-02-19)
反应信号挖掘中的应用[J]. 中南药学,2018,16(2): (编辑:舒安琴)
· 1510 · China Pharmacy 2024 Vol. 35 No. 12 中国药房 2024年第35卷第12期